The neuronal ceroid-lipofuscinoses: From past to present

被引:173
|
作者
Haltia, Matti
机构
[1] Univ Helsinki, Dept Pathol, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Helsinki 00014, Finland
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2006年 / 1762卷 / 10期
关键词
neuronal ceroid lipofuscinoses; batten disease; lysosomal storage; molecular pathology; classification;
D O I
10.1016/j.bbadis.2006.06.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neuronal ceroid-lipofuscinoses (NCLs) are inherited lysosomal storage diseases and constitute the most common group of children's progressive encephalopathies. Most childhood forms of NCL are clinically characterized by progressive loss of vision as well as mental and motor deterioration, epileptic seizures, and premature death, while the rare adult forms are dominated by dementia. All forms of NCL share common pathomorphological features. Autofluorescent, periodic acid-Schiff- and Sudan black B-positive granules, resistant to lipid solvents, accumulate in the cytoplasm of most nerve cells, and there is progressive and remarkably selective neuronal degeneration and loss. For a long time, the NCLs were grouped under the heading of the "amaurotic family idiocies" and conceived as lipidoses. However, in the late 1980ies and 1990ies the NCL storage cytosomes were shown to consist largely of two hydrophobic proteins: either subunit c of mitochondrial ATP synthase or sphingolipid activator proteins A and D. Since 1995 numerous mutations in at least seven different genes have been shown to underlie the multiple human and animal forms of NCL. This review discusses the historical evolution of the NCL concept and the impact of the recent biochemical and molecular genetic findings on our views on the classification and pathogenesis of these devastating brain disorders. (c) 2006 Elsevier B.V All rights reserved.
引用
收藏
页码:850 / 856
页数:7
相关论文
共 50 条
  • [21] Therapeutic Approaches to the Challenge of Neuronal Ceroid Lipofuscinoses
    Kohan, R.
    Cismondi, I. A.
    Oller-Ramirez, A. M.
    Guelbert, N.
    Tapia Anzolini, V.
    Alonso, G.
    Mole, S. E.
    Dodelson de Kremer, R.
    Noher de Halac, I.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (06) : 867 - 883
  • [22] FUNDUSCOPIC AND ANGIOGRAPHIC APPEARANCE IN THE NEURONAL CEROID LIPOFUSCINOSES
    Hainsworth, Dean P.
    Liu, Grace T.
    Hamm, Charles W.
    Katz, Martin L.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (05): : 657 - 668
  • [23] Neurophysiological Findings in Neuronal Ceroid Lipofuscinoses
    Trivisano, Marina
    Ferretti, Alessandro
    Calabrese, Costanza
    Pietrafusa, Nicola
    Piscitello, Ludovica
    Pavia, Giusy Carfi'
    Vigevano, Federico
    Specchio, Nicola
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [24] INCIDENCE OF NEURONAL CEROID-LIPOFUSCINOSES IN WEST-GERMANY - VARIATION OF A METHOD FOR STUDYING AUTOSOMAL RECESSIVE DISORDERS
    CLAUSSEN, M
    HEIM, P
    KNISPEL, J
    GOEBEL, HH
    KOHLSCHUTTER, A
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1992, 42 (04): : 536 - 538
  • [25] Bioinformatic perspectives in the neuronal ceroid lipofuscinoses
    Kmoch, Stanislav
    Stranecky, Viktor
    Emes, Richard D.
    Mitchison, Hannah M.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2013, 1832 (11): : 1831 - 1841
  • [26] Molecular genetics of the neuronal ceroid lipofuscinoses
    Mole, S
    Gardiner, M
    EPILEPSIA, 1999, 40 : 29 - 32
  • [27] Experimental therapies in the neuronal ceroid lipofuscinoses
    Neverman, Nicole J.
    Best, Hannah L.
    Hofmann, Sandra L.
    Hughes, Stephanie M.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2015, 1852 (10): : 2292 - 2300
  • [28] The neuronal ceroid lipofuscinoses: the same, but different?
    Cooper, Jonathan D.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2010, 38 : 1448 - 1452
  • [29] Progress in neuropathology of the neuronal ceroid lipofuscinoses
    Goebel, HH
    Schochet, SS
    Jaynes, M
    Brück, W
    Kohlschütter, A
    Hentati, F
    MOLECULAR GENETICS AND METABOLISM, 1999, 66 (04) : 367 - 372
  • [30] Applying modern Omic technologies to the Neuronal Ceroid Lipofuscinoses
    Kline, Rachel A.
    Wishart, Thomas M.
    Mills, Kevin
    Heywood, Wendy E.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (09):